Acadian Asset Management LLC Travere Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 16,452 shares of TVTX stock, worth $287,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,452
Previous 144,901
88.65%
Holding current value
$287,910
Previous $1.19 Million
80.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TVTX
# of Institutions
193Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$134 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$134 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$121 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$82 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$76 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.12B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...